Folfirinox vs. Gemcitabine + Nab-Paclitaxel as the First-Line Treatment for Pancreatic Cancer: A Systematic Review and Meta-Analysis

BACKGROUND: The efficacy and safety of Folfirinox (FFX) or gemcitabine + nab-paclitaxel (GnP) to be used as the first-line drugs for pancreatic cancer (PC) is yet to be established. We conducted an analysis of retrospective studies to assess the efficacy and safety of these two regimens by comparing...

Descripción completa

Detalles Bibliográficos
Autores principales: Merza, Nooraldin, Farooqui, Sabeeh Khawar, Dar, Sophia Haroon, Varughese, Tony, Awan, Rehmat Ullah, Qureshi, Lamaan, Ansari, Saad Ali, Qureshi, Hadi, Mcilvaine, Jamie, Vohra, Ishaan, Nawras, Yusuf, Kobeissy, Abdallah, Hassan, Mona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588495/
https://www.ncbi.nlm.nih.gov/pubmed/37869244
http://dx.doi.org/10.14740/wjon1604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588495/
https://www.ncbi.nlm.nih.gov/pubmed/37869244
http://dx.doi.org/10.14740/wjon1604

Ejemplares similares